(株)ペルセウスプロテオミクスの貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4882/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/03/21日証協無担保0株-100%0株0%73,143株+251.65%
2025/03/21日証協有担保637,708株-60.19%22,751株-13.82%202,700株+23.52%
2025/03/14日証協無担保1,200株0%0株0%20,800株-44.53%
2025/03/14日証協有担保1,601,835株+36.5%26,400株+4.76%164,100株+160.89%
2025/03/07日証協無担保0株0%0株0%37,501株-22.04%
2025/03/07日証協有担保1,173,465株+19.37%25,200株-77.72%62,900株-74.81%
2025/02/28日証協無担保0株0%0株0%48,100株-41.63%
2025/02/28日証協有担保983,040株-9.6%113,100株+40.32%249,700株+124.15%
2025/02/21日証協無担保0株0%0株0%82,407株+9.44%
2025/02/21日証協有担保1,087,400株+8.07%80,600株+28.14%111,400株+89.12%
2025/02/14日証協無担保0株0%0株0%75,300株+311.48%
2025/02/14日証協有担保1,006,174株-2.57%62,900株+165.43%58,903株+109.62%
2025/02/07日証協無担保0株0%0株0%18,300株-66.3%
2025/02/07日証協有担保1,032,683株-6.85%23,697株-75.72%28,100株-78.98%
2025/01/31日証協無担保0株0%0株0%54,300株-4.74%
2025/01/31日証協有担保1,108,597株-47.69%97,600株+26.23%133,700株+36.29%
2025/01/24日証協無担保0株0%0株0%57,002株+44.28%
2025/01/24日証協有担保2,119,365株+182.65%77,317株+119.03%98,100株+31.15%
2025/01/17日証協無担保0株0%0株-100%39,509株-12.98%
2025/01/17日証協有担保749,832株-59.29%35,300株-60.38%74,800株-70.47%
2025/01/10日証協無担保0株0%100株0%45,400株+291.28%
2025/01/10日証協有担保1,842,014株+701.08%89,091株+226.34%253,300株+897.24%
2024/12/30日証協無担保0株0%0株0%11,603株-91.45%
2024/12/30日証協有担保229,941株-87.37%27,300株-72.8%25,400株-86.28%
2024/12/27日証協無担保0株0%0株0%135,705株+10.69%
2024/12/27日証協有担保1,820,241株-38.96%100,384株-61.3%185,100株-49.29%
2024/12/20日証協無担保0株0%0株0%122,601株+6.35%
2024/12/20日証協有担保2,981,907株+49.7%259,407株-7.29%365,000株+10.17%
2024/12/13日証協無担保0株0%0株0%115,280株+120.84%
2024/12/13日証協有担保1,991,900株+11.97%279,800株+52.98%331,300株+19.6%
2024/12/06日証協無担保0株0%0株0%52,200株-73.54%
2024/12/06日証協有担保1,778,900株+41.25%182,900株+872.87%277,000株+70.99%
2024/11/29日証協無担保0株0%0株0%197,300株+259.89%
2024/11/29日証協有担保1,259,400株-58.6%18,800株-29.59%162,000株-61.75%
2024/11/22日証協無担保0株0%0株0%54,823株+24.03%
2024/11/22日証協有担保3,041,700株+63.99%26,700株+584.62%423,500株+220.59%
2024/11/15日証協無担保0株0%0株-100%44,200株+13.62%
2024/11/15日証協有担保1,854,800株+100.35%3,900株-89.26%132,100株-42.29%

※株式分割は考慮していませんのでご注意ください。

Page Top